|
Book Title: Treating and Preventing Adolescent Mental Health Disorders
> pp. [671]
UNDEFINED: AUTHORS
Treating and Preventing Adolescent Mental Health Disorders
Print ISBN 9780195173642, 2005
pp. [671]
schizophrenia. Journal of Child Psychology and Psychiatry, 29, 865–878.
Watt, N. F. (1978). Patterns of childhood social development in adult schizophrenics. Archives of General Psychiatry, 35, 160–165.
Watt, N., & Saiz, C. (1991). Longitudinal studies of premorbid development of adult schizophrenics. In E. Walker (Ed.), Schizophrenia: A life-course developmental perspective (pp. 158–185). San Diego: Academic Press.
Weinberger, D. (1986). The pathogenesis of schizophrenia: A neurodevelopmental theory. In H. Nasrallah & D. Weinberger (Eds.), The neurobiology of schizophrenia (pp. 397–406). Amsterdam: Elsevier Science Publishers.
Weinberger, D. R. (1987). Implications of normal brain development for the pathogenesis of schizophrenia. Archives of General Psychiatry, 44, 660–669.
Weinberger, D. R., Berman, K. F., Suddath, R., & Torrey, E. F. (1992). Evidence of dysfunction of a prefrontal-limbic network in schizophrenia: A magnetic resonance imaging and regional cerebral blood flow study of discordant monozygotic twins. American Journal of Psychiatry, 149, 890–897.
Weinberger, D. R., Egan, M. F., Bertolino, A., Calicott, J. H., Mattay, V. S., Lipska, B. K., et al. (2001). Prefrontal neurons and the genetics of schizophrenia. Biological Psychiatry, 50, 825–844.
Weinstein, D. D., Diforio, D., Schiffman, J., Walker, E., & Bonsall, R. (1999). Minor physical anomalies, dermatoglyphic asymmetries, and cortisol levels in adolescents with schizotypal personality disorder. American Journal of Psychiatry, 156, 617–623.
Werry, J. S. (1981). Drugs and learning. Journal of Child Psychology and Psychiatry, 22, 283–290.
Werry, J. S., McClellan, J. M., & Chard, L. (1991).
Childhood and adolescent schizophrenic, bipolar, and schizoaffective disorders: A clinical and outcome study. Journal of the American Academy of Child and Adolescent Psychiatry, 30, 457–465.
Wible, C. F., Kubicki, M., Yoo, S-S, Kacher, D. F., Salisbury, D. F., Anderson, M. C., et al. (2001). A functional magnetic resonance imaging study of auditory mismatch in schizophrenia. American Journal of Psychiatry, 158, 938–943.
Wiersma, D., Wanderling, J., Dragomirecka, E., Ganev, K., Harrison, G., an der Heiden, W., et al. (2000). Social disability in schizophrenia: Its development and prediction over 15 years in incidence cohorts in six European centres. Psychological Medicine, 30, 1155–1167.
Wiersma, D., Nienhuis, F. J., Slooff, C. J., & Giel, R. (1998). Natural course of schizophrenic disorders: A 15-year follow-up of a Dutch incidence cohort. Schizophrenia Bulletin, 24, 75–85.
Wolff, A. L., & O'Driscoll, G. A. (1999). Motor deficits and schizophrenia: The evidence from neuroleptic-naive patients and populations at risk. Journal of Psychiatry and Neuroscience, 24, 304–314.
Wood, S. J., Pantelis, C., Proffitt, T., Phillips, L. J., Stuart, G. W., Buchanan, J.-A., et al. (2003). Spatial working memory ability is a marker of risk-for-psychosis. Psychological Medicine, 33, 1239–1247.
Woods, S. W., Miller, T. J., Davidson, L., Hawkins, K. A., Sernyak, M. J., & McGlashan, T. H. (2001). Estimated yield of early detection of prodromal or first episode patients by screening first-degree relatives of schizophrenic patients. Schizophrenia Research, 52, 21–27.
Woods, S., Zipursky, R., Perkins, D., Addington, J., Marquez, E., Breier, A., et al. (2002). Olanzapine vs. placebo for prodromal symptoms. Acta Psychiatrica Scandinavica, 106, 43.
World Health Organization. (1992). International classification of diseases (10th revision). Geneva: Author.
Wykes, T., Reeder, C., Williams, C., Corner, J., Rice, C., & Everitt, B. (2001). Are the effects of cognitive remediation therapy (CRT) durable? Results from an exploratory trial in schizophrenia. Schizophrenia Research, 61, 163–174.
end p.671
|
|
|
|
